Novo Nordisk regains membership in UK pharma body Ruchika Sharma18 March 2025 3:30 PM ISTLondon: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...
CagriSema demonstrates superior weight loss in adults with obesity, type 2 diabetes in REDEFINE 2 trial: Novo Nordisk Ruchika Sharma14 March 2025 2:00 PM ISTDenmark: CagriSema has demonstrated superior weight loss in adults with obesity or overweight and type 2 diabetes in the REDEFINE 2 trial, Novo...
Novo Nordisk Ozempic get USFDA nod for reduction of kidney disease worsening risk, cardiovascular death in adults with type 2 diabetes, chronic kidney disease Ruchika Sharma29 Jan 2025 1:30 PM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic to reduce the risk of kidney disease...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Novo Nordisk bleeding disorder injection gets USFDA nod Ruchika Sharma21 Dec 2024 11:30 AM ISTPlainsboro: Novo Nordisk has announced that the U.S. Food and Drug Administration (FDA) has approved Alhemo (concizumab-mtci) injection as a...
Website unlawfully selling versions of Novo Nordisk weight loss drugs gets USFDA warning Ruchika Sharma3 July 2024 6:45 PM ISTThe U.S. Food and Drug Administration (USFDA) said on tuesday it had issued a warning against a website called ozempen.com for illegally selling...
Biocon quest for partner in China to test generic versions of Novo Nordisk Wegovy, Ozempic Ruchika Sharma21 Jun 2024 3:56 PM ISTShanghai: Biocon is looking for a partner in China to test generic versions of Novo Nordisk's weight loss treatment Wegovy and diabetes...
USFDA panel votes against Novo Nordisk weekly insulin use in type 1 diabetes patients Ruchika Sharma26 May 2024 3:00 PM ISTAdvisers to the U.S. health regulator cast their votes opposing the utilization of Novo Nordisk's weekly insulin for patients with type 1 diabetes,...
Flagship Pioneering, Metaphore Biotechnologies partner Novo Nordisk to develop next-Generation Therapeutics for Obesity Management Ruchika Sharma12 May 2024 12:15 PM ISTCambridge: Metaphore Biotechnologies, a Flagship-founded biotechnology company designing novel therapeutics by combining machine learning and...
Novo Nordisk to acquire Cardior Pharma for up to 1.025 billion Euros Ruchika Sharma27 March 2024 1:30 PM ISTDenmark Novo Nordisk and Cardior Pharmaceuticals have announced that Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros,...
Novo Nordisk Awiqli recommended for approval for diabetes by European regulatory authorities Ruchika Sharma23 March 2024 2:12 PM ISTAwiqli is a once-weekly basal insulin analogue designed to cover the basal insulin requirements for a full week with a single subcutaneous injection.
Novo Nordisk hopes to launch weight loss pill Amycretin this decade Ruchika Sharma11 March 2024 12:50 PM ISTNovo's current plan is to advance the development of amycretin in its oral and injectable form simultaneously, and it gives a regulatory advantage to...
